A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT01303796 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

482

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Sapacitabine
DRUG: Decitabine

Sponsor

Cyclacel Pharmaceuticals, Inc.